The pedicled transverse rectus abdominis myocutaneous (TRAM) flap is a workhorse of autologous breast reconstruction. The main drawback most surgeons have with this option is in the donor site morbidity. Very often, the rectus sheath cannot be closed primarily and the defect has to be bridged using a mesh. Even if the rectus sheath can be apposed, the patient is at risk of having an abdominal hernia from weakness of the abdominal wall. The ideal situation, elaborates Dr Ong, would be to use a non-permanent on-lay graft over the primary repair to strengthen the sheath repair. The graft would give additional strength until fibrosis has set in to provide the additional strength to the repair, and then the mesh would resorb, to minimize the problems associated with the use of a permanent mesh.

"We assessed the early results with the use of a synthetic resorbable mesh as an on-lay graft over our rectus sheath repair in patients who had undergone pedicled TRAM flap for breast reconstruction. All patients were randomized into either using this synthetic resorbable mesh (TIGR® Matrix Surgical Mesh) or a synthetic permanent mesh. Data was collected prospectively, as well as on follow up. Our results showed that there was no significant difference in complication rates between the two groups, up to a follow up of 1 year. There was no difference in patient recovery, hospitalization stay, and pain scores,"said Dr. Ong Wei Chen, Consultant Plastic Surgeon, Division of Plastic, Reconstructive and Aesthetic Surgery - National University Hospital, Singapore.

"This randomized controlled study has shown not only that TIGR® Matrix may well be a suitable resorbable on-lay mesh for use in repair of the rectus sheath after TRAM flap surgery, but it also supports the belief increasingly articulated by general and plastic surgeons around the world, that the world's first long-term resorbable synthetic mesh has opened up a new approach to treating a range of defects requiring reinforcement of soft tissue where weakness exists," said Tac-Whei Ong, VP Global Sales & Marketing, Novus Scientific.

We look forward to sharing the results of the study in a Symposium given by Dr Ong Wei Chen at CHA level 2, The Traders Hotel, Penang Malaysia at 5.15pm on Saturday the 31st of March. For full information of the event in general, please select the MAPACS event here: http://novusscientific.com/events/.

TIGR® Matrix Surgical Mesh is available for sale in the U.S. and selected countries in Europe and Asia.

About Novus ScientificNovus Scientific (www.novusscientific.com) is an innovator in the development and commercialization of resorbable synthetic medical devices.

(Date:10/13/2017)... ... October 13, 2017 , ... Many families have long-term insurance ... care insurance companies have a waiver for care if the client has a cognitive ... the family pays for care, is often waived, so the benefits from their insurance ...

(Date:10/13/2017)... (PRWEB) , ... October 13, 2017 , ... Global Healthcare ... scenic Alexandria Park in Milford, NJ. This free event, sponsored by Global Healthcare ... activity. The fun run is geared towards children of all ages; it is ...

(Date:10/13/2017)... ... 13, 2017 , ... Coveros, a leader in agile coaching ... contract by the Center for Medicare and Medicaid Services (CMS). The Enterprise Agile ... of Agile methodologies in a consistent and high value manner across CMS programs. ...

(Date:10/12/2017)... ... October 12, 2017 , ... First Healthcare Compliance (FHC), an ... showcase a range of technology and learning solutions at the 68th Annual American ... to be held October 14–18, 2017 at the Mandalay Bay Resort in Las ...